HUT54041A - Process for producing stable pharmaceutical compositions - Google Patents

Process for producing stable pharmaceutical compositions

Info

Publication number
HUT54041A
HUT54041A HU892994A HU299489A HUT54041A HU T54041 A HUT54041 A HU T54041A HU 892994 A HU892994 A HU 892994A HU 299489 A HU299489 A HU 299489A HU T54041 A HUT54041 A HU T54041A
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
stable pharmaceutical
producing stable
producing
compositions
Prior art date
Application number
HU892994A
Other languages
English (en)
Other versions
HU892994D0 (en
Inventor
Leonard S Rosenberg
Cheryl K Black
Earl R Speicher
Dietmar M Wagenknecht
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of HU892994D0 publication Critical patent/HU892994D0/hu
Publication of HUT54041A publication Critical patent/HUT54041A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU892994A 1988-06-08 1989-05-04 Process for producing stable pharmaceutical compositions HUT54041A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/203,836 US4857552A (en) 1988-06-08 1988-06-08 Stable pharmaceutical composition

Publications (2)

Publication Number Publication Date
HU892994D0 HU892994D0 (en) 1990-11-28
HUT54041A true HUT54041A (en) 1991-01-28

Family

ID=22755531

Family Applications (1)

Application Number Title Priority Date Filing Date
HU892994A HUT54041A (en) 1988-06-08 1989-05-04 Process for producing stable pharmaceutical compositions

Country Status (13)

Country Link
US (1) US4857552A (hu)
EP (1) EP0403578B1 (hu)
JP (1) JP2552372B2 (hu)
AU (1) AU613196B2 (hu)
CA (1) CA1334001C (hu)
DE (1) DE68918847T2 (hu)
DK (1) DK32490A (hu)
HU (1) HUT54041A (hu)
IL (1) IL90551A (hu)
MY (1) MY104030A (hu)
NZ (1) NZ229410A (hu)
WO (1) WO1989011855A1 (hu)
ZA (1) ZA894344B (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405376A (en) * 1993-08-27 1995-04-11 Medtronic, Inc. Method and apparatus for ablation
WO1999007354A2 (en) * 1997-08-08 1999-02-18 Duke University Compositions, apparatus and methods for facilitating surgical procedures
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
US6310094B1 (en) * 2001-01-12 2001-10-30 Baxter International Inc. Ready-to-use esmolol solution
TWI277414B (en) * 2001-01-12 2007-04-01 Baxter Int Esmolol formulation
CA2461349C (en) 2001-09-26 2011-11-29 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
EP1417962A1 (de) * 2002-11-06 2004-05-12 AOP Orphan Pharmaceuticals AG Verfahren zur Herstellung eines Arzneimittels enthaltend Esmolol
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
AU2014203121B2 (en) * 2007-05-22 2016-04-21 Baxter Healthcare Sa Concentrate esmolol
DK2234614T3 (da) 2007-12-21 2013-02-11 Aop Orphan Pharmaceuticals Ag Farmaceutisk sammensætning til parenteral administration af et ultrakort virkende beta-receptorblokerende middel
DK2480204T3 (da) * 2009-09-22 2014-02-03 Vlife Sciences Technologies Pvt Ltd Topikal formulering til diabetiske fodsår
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
US20120053240A1 (en) * 2009-12-18 2012-03-01 Metabolic Technologies, Inc. Method of Administering beta-hydroxy-beta-methylbutyrate (HMB)
BR112013016701A2 (pt) 2011-01-27 2017-07-04 Baxter Healthcare Sa métodos para tratar a taquicardia e/ou controlar a frequência cardíaca enquanto minimiza e/ou controla a hipotensão.
MX2013008715A (es) 2011-01-27 2013-08-29 Baxter Healthcare Sa Uso de (s) -esmolol para controlar la irritacion venosa asociada con el tratamiento de un padecimiento cardiaco.
US8835505B1 (en) * 2013-03-15 2014-09-16 Welgrace Research Group Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
CN104473869A (zh) * 2014-11-20 2015-04-01 北京京科泰来科技有限公司 一种艾司洛尔脂肪乳及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
AU575153B2 (en) * 1984-04-09 1988-07-21 Du Pont Merck Pharmaceutical Company, The Pharmaceutical compositions and method for treatment for prophylaxis of cardiac disorders

Also Published As

Publication number Publication date
DE68918847D1 (de) 1994-11-17
US4857552A (en) 1989-08-15
DK32490D0 (da) 1990-02-07
EP0403578B1 (en) 1994-10-12
JPH03500658A (ja) 1991-02-14
CA1334001C (en) 1995-01-17
EP0403578A1 (en) 1990-12-27
DE68918847T2 (de) 1995-03-16
DK32490A (da) 1990-02-07
AU613196B2 (en) 1991-07-25
EP0403578A4 (en) 1991-07-03
JP2552372B2 (ja) 1996-11-13
AU3570489A (en) 1990-01-05
WO1989011855A1 (en) 1989-12-14
MY104030A (en) 1993-10-30
IL90551A (en) 1992-12-01
ZA894344B (en) 1991-02-27
HU892994D0 (en) 1990-11-28
IL90551A0 (en) 1990-01-18
NZ229410A (en) 1991-10-25

Similar Documents

Publication Publication Date Title
HUT49290A (en) Process for producing retarde pharmaceutical compositions
HUT50851A (en) Process for producing intervenous pharmaceutical compositions
HUT48900A (en) Process for producing phosphoruus-containing squalene-synthetase inhibitores and pharmaceutical compositions containing them
HUT53644A (en) Process for producing pharmaceutical nukleozides and pharmaceutical compositions containing them
HUT58326A (en) Process for producing pipeidine derivatives and pharmaceutical compositions containing them
HUT49316A (en) Process for producing didehydro-d3-vitamine derivatives and pharmaceutical compositions containing them
HUT48267A (en) Process for producing fluoro-citidin derivatives and pharmaceutical compositions containing them
HUT51613A (en) Process for producing piperidinyl-benzimidazole derivatives and pharmaceutical compositions containing these compounds
HUT54046A (en) Process for producing pharmaceutical compositions
HUT58304A (en) Process for producing quinazolin-3-alkane-acids and pharmaceutical compositions containing them
HUT48887A (en) Process for producing cyclopentenyl-purin derivatives and pharmaceutical compositions containing them
HUT54041A (en) Process for producing stable pharmaceutical compositions
HUT56098A (en) Process for producing azanaphtalenesultame derivatives and pharmaceutical compositions containing them
HUT59908A (en) Process for producing benzazepine- and benzo-thiazepine derivatives and pharmaceutical compositions containing them
HUT49317A (en) Process for producing 16-dehydro-d3-vitamine derivatives and pharmaceutical compositions containing them
HUT47079A (en) Process for producing n-amino-butyl-n-phenyl-aryl-amide derivatives and pharmaceutical compositions containing them
HUT56078A (en) Process for producing piridazine derivatives and pharmaceutical compositions containing them
HUT50473A (en) Process for producing imidazopyridazinones and pharmaceutical compositions comprising such compounds
HUT56342A (en) Process for producing capsoicin derivatives and pharmaceutical compositions comprising such compounds
HU906358D0 (en) Process for producing nukleosides and pharmaceutical compositions containing them
HUT50829A (en) Process for producing thienoazepines and pharmaceutical compositions comprising same
HUT58739A (en) Process for producing 3-oxo-3-/benzopyrano- or -thiopyrano-pyrazol-3-yl/-propionitril derivatives and pharmaceutical compositions containing them
HUT56373A (en) Process for producing pyranobenzoxadiazole derivatives and pharmaceutical compositions comprising such compounds
HUT48244A (en) Process for producing isoxazol-3-carbolin derivatives and pharmaceutical compositions containing them
HUT46692A (en) Process for producing imidazo-pyridine derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: THE DU PONT MERCK PHARMACEUTICAL CO., US